Mazdutide
$171.99
This material is supplied solely as a laboratory research article. Buyer is responsible for ensuring lawful purchase, handling, storage, and use. We do not provide administration or therapeutic guidance.
Mazdutide - Dual GLP-1/Glucagon Receptor Agonist Peptide, Research Reference Material
Analytical Identity
| Common name | Mazdutide |
|---|---|
| Amino-acid sequence | HSQGTFTSDYSKYLDEKRAKDFVQWLLNT (modified dual agonist analog) |
| Sequence (3-letter) | His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Arg-Ala-Lys-Asp-Phe-Val-Gln-Trp-Leu-Leu-Asn-Thr |
| Residues | 29 |
| CAS Number | 2107529-15-7 |
| Molecular formula | C194H295N47O59 |
|---|---|
| Molecular weight | ~4332 g/mol |
| Appearance | White to off-white lyophilized powder |
| Physical form | Lyophilized powder |
| Purity | Not less than 98% by HPLC (see lot-specific Certificate of Analysis) |
|---|---|
| Source | Synthetic |
| Catalog / SKU | Mazdutide |
Mazdutide is supplied as a laboratory research reference material intended strictly for in-vitro and laboratory research use only. The compound is a synthetic 29-residue peptide analog engineered as a dual agonist scaffold targeting GLP-1 and glucagon receptor pharmacology in benchtop assay systems. Its verified identifiers are CAS 2107529-15-7, molecular formula C194H295N47O59, and a calculated monoisotopic molecular weight of approximately 4332 g/mol, corresponding to the primary sequence HSQGTFTSDYSKYLDEKRAKDFVQWLLNT (modified dual agonist analog).
The full three-letter sequence, His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Arg-Ala-Lys-Asp-Phe-Val-Gln-Trp-Leu-Leu-Asn-Thr, reflects a glucagon-family backbone bearing His at position 1 and internal Lys residues that serve as recognized handles for side-chain modification in dual-agonist scaffolds. The composition includes a single Trp residue (useful for UV quantitation near 280 nm), one Arg, three Lys, and multiple acidic Asp/Glu positions that together shape the peptide's isoelectric behavior and chromatographic retention profile.
Physically, Mazdutide is supplied as a synthetic white to off-white lyophilized powder. Purity is specified as not less than 98% by HPLC, with the exact analytical release values, retention time, mass confirmation and net peptide content documented on the lot-specific Certificate of Analysis, available on request. The lyophilized format is intended to support gravimetric handling, reconstitution studies, reference-standard cross-comparison, HPLC/UPLC method development, LC-MS identity confirmation, and stability-indicating assay work in a controlled laboratory environment.
Published scientific literature has examined Mazdutide in preclinical research contexts, and the material is offered here solely to support that type of analytical and in-vitro investigation. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding this material and provides no administration or dosing guidance of any kind. This material is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. It is sold exclusively to qualified research professionals and institutional laboratories for legitimate scientific characterization.
Physical format
Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.
Certificate of Analysis
| Analyte | Mazdutide |
|---|---|
| CAS Number | 2107529-15-7 |
| Appearance | White to off-white lyophilized powder |
| Identity | Confirmed by HPLC and mass spectrometry |
Lot-specific COA available — contact [email protected] with your lot number.
Storage & handling
Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.
Scientific references
The following are independent, peer-reviewed publications provided for reference. They describe third-party research and are not representations by POWER BIOTECH LLC regarding this product.
- Mazdutide for overweight or obesity in Chinese adults: a randomized, double-blind, placebo-controlled phase 2 trial — https://pubmed.ncbi.nlm.nih.gov/38432214/
- A phase 1 randomized trial to evaluate safety, pharmacokinetics, and pharmacodynamics of IBI362 (LY3305677) in Chinese overweight or obese adults — https://pubmed.ncbi.nlm.nih.gov/35279259/
- Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial — https://pmc.ncbi.nlm.nih.gov/articles/PMC10523123/
- Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity — https://pubmed.ncbi.nlm.nih.gov/31168213/
- Glucagon-like peptide-1 and glucagon receptor co-agonists: novel therapeutics for obesity and type 2 diabetes — https://pmc.ncbi.nlm.nih.gov/articles/PMC8782626/
Eligibility & terms of sale
This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.
FAQ
What is the purity and how is it verified?
Not less than 98% by HPLC; see the Certificate of Analysis for the lot-specific result.
What form does it ship in?
A lyophilized powder in a sealed vial.
Can you advise on dosing, reconstitution, or administration?
No. We provide batch documentation, storage, and handling information only; we do not provide dosing, reconstitution, administration, or therapeutic guidance.
Is lot-specific documentation available?
Yes - contact [email protected] with your lot number for the Certificate of Analysis.
Related reference materials
Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.
